The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.